Rheumatic manifestations of malignancy.
Rheumatic manifestations of malignancy include a wide spectrum of osteoarticular, muscular, glandular, endocrinologic, and systemic features, posing a therapeutic challenge. The clinician should be aware that Sjögren's syndrome, polymyositisdermatomyositis, rheumatoid and rheumatoid-like arthritis, polymyalgia rheumatica and temporal arteritis, and diverse osteomuscular conditions may be the immunopathogenic features of a neoplasm, the direct consequence of osteomuscular tumors, the effect of tumor-associated hormones, or the consequence of cancer therapy. The principal articles that have appeared in the past year on these associations are discussed. We also review the association of x-ray irradiation and cancer in patients with ankylosing spondylitis.
Aviña-Zubieta
J A
JA
Rheumatic Disease Unit, Hospital de Especialidades Centro Medico La Raza, Mexico City, Mexico.
Enkerlin
H L
HL
Galindo-Rodriguez
G
G
D000970:Antineoplastic Agents / Q000009:adverse effects; D001859:Bone Neoplasms / Q000150:complications; D006801:Humans; D007592:Joint Diseases / Q000150:complications; D009369:Neoplasms / Q000150:complications*; D012216:Rheumatic Diseases / Q000139:chemically induced / Q000209:etiology*; D012983:Soft Tissue Neoplasms / Q000150:complications
D000970:Antineoplastic Agents